| 2026-04-30 |
股东大会：
将于2026-06-26召开股东大会
会议内容 ▼▲
- 1.To elect two Class III directors, Arvind Kush and Dennis Berman, to the Board of Directors, each to serve until the Company’s 2029 annual meeting of stockholders and until his successor is duly elected and qualified, or until his earlier death, resignation or removal;
2.To ratify the appointment of CohnReznick LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026;
3.To approve an amendment to the Company’s certificate of incorporation to limit the liability of certain officers of the Company as permitted by Delaware law;
4.To approve an amendment to the Company’s 2020 Equity Incentive Plan to increase the authorized number of shares of common stock reserved for issuance by 3,000,000 shares;
5.To approve, on a non-binding, advisory basis, the compensation of the Company’s named executive officers;
6.To vote, on a non-binding, advisory basis, on the frequency of future non-binding, advisory votes on compensation of the Company’s named executive officers;
7.To consider and act upon such other matters as may properly come before the meeting or any postponement or adjournment of the meeting.
|
| 2026-04-30 |
详情>>
股本变动：
变动后总股本13203.26万股
|
| 2026-03-26 |
详情>>
业绩披露：
2025年年报每股收益-0.49美元,归母净利润-4825.92万美元,同比去年增长-75.36%
|
| 2026-02-21 |
详情>>
内部人交易：
Aurentz Vincent等共交易3笔
|
| 2025-11-14 |
详情>>
业绩披露：
2025年三季报(累计)每股收益-0.4美元,归母净利润-3552.45万美元,同比去年增长-130.87%
|
| 2025-08-14 |
详情>>
业绩披露：
2025年中报每股收益-0.26美元,归母净利润-2359.43万美元,同比去年增长-145.54%
|
| 2025-05-14 |
详情>>
业绩披露：
2025年一季报每股收益-0.15美元,归母净利润-1367.87万美元,同比去年增长-194.19%
|
| 2025-05-12 |
股东大会：
将于2025-06-27召开股东大会
会议内容 ▼▲
- 1.To elect two Class II directors, Amit Munshi and David Canner, Ph.D., to the Board of Directors, each to serve until the Company’s 2028 annual meeting of stockholders and until his successor is duly elected and qualified, or until his earlier death, resignation or removal;
2.To ratify the appointment of CohnReznick LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2025;
3.To approve an amendment to the Company’s 2020 Equity Incentive Plan to include an automatic “evergreen” provision and to extend the term of such plan;
4.To consider and act upon such other matters as may properly come before the meeting or any postponement or adjournment of the meeting.
|
| 2025-03-27 |
详情>>
业绩披露：
2024年年报每股收益-1.16美元,归母净利润-2751.99万美元,同比去年增长-44.62%
|
| 2024-11-18 |
股东大会：
将于2025-01-03召开股东大会
会议内容 ▼▲
- 1.To approve an amendment to Section 1 of Article IV of our Amended and Restated Certificate of Incorporation to increase the number of authorized shares of common stock from 100,000,000 shares to 500,000,000 shares;
2.To approve an amendment to our 2020 Equity Incentive Plan to increase the number of authorized shares of common stock reserved for issuance by 27,453,993 shares;
3.To approve the repricing of certain outstanding stock options;
4.To approve an amendment to Article XII of our Amended and Restated Certificate of Incorporation to eliminate the 66 2/3% affirmative vote requirement for amendments to Section 1 of Article IV thereof, which governs the classes and amount of stock we are authorized to issue;
5.To consider and act upon such other matters as may properly come before the meeting or any postponement or adjournment of the meeting.
|
| 2024-11-14 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-2.03美元,归母净利润-1538.73万美元,同比去年增长-3.61%
|
| 2024-08-14 |
详情>>
业绩披露：
2024年中报每股收益-1.38美元,归母净利润-960.92万美元,同比去年增长6.30%
|
| 2024-08-14 |
财报披露：
美东时间 2024-08-14 盘后发布财报
|
| 2024-06-20 |
股东大会：
将于2024-08-05召开股东大会
会议内容 ▼▲
- 1.To approve, in accordance with Nasdaq Listing Rule 5635(d), the issuance of certain common stock purchase warrants in connection with a private placement and in connection with a warrant inducement (the “Warrant Issuance Proposal”)
2.To consider and act upon such other matters as may properly come before the meeting or any postponement or adjournment of the meeting.
|
| 2024-05-15 |
详情>>
业绩披露：
2024年一季报每股收益-0.73美元,归母净利润-464.96万美元,同比去年增长-3.84%
|
| 2024-04-26 |
股东大会：
将于2024-06-07召开股东大会
会议内容 ▼▲
- 1.To elect one director to the Board of Directors of the Company (the “Board of Directors”) to serve as a Class I director, to serve until the Company’s 2027 annual meeting of stockholders, or until his successor is duly elected and qualified;
2.To ratify the appointment of CohnReznick LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024;
3.To approve an amendment to the Company’s 2020 Equity Incentive Plan to increase the number of authorized shares of common stock reserved for issuance by 2,500,000 shares to replenish the number of authorized shares of common stock available for future grants;
4.To approve an amendment to Article XII of our Amended and Restated Certificate of Incorporation (the “Certificate of Incorporation”) to eliminate the 66 2/3% affirmative vote requirement for amendments to Section 1 of Article IV thereof;
5.To consider and act upon such other matters as may properly come before the meeting or any postponement or adjournment of the meeting.
|
| 2024-03-27 |
详情>>
业绩披露：
2023年年报每股收益-3.57美元,归母净利润-1902.89万美元,同比去年增长-5.4%
|
| 2023-11-14 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-2.93美元,归母净利润-1485.09万美元,同比去年增长-7.81%
|
| 2023-06-30 |
详情>>
拆分方案：
每6.0000合并分成1.0000股
|
| 2023-05-05 |
股东大会：
将于2023-06-23召开股东大会
会议内容 ▼▲
- 1.To elect two directors to the Board of Directors of the Company (the “Board of Directors”) to serve as Class III directors, to serve until the Company’s 2026 annual meeting of stockholders, or until in each case their respective successor is duly elected and qualified;
2.To grant discretionary authority to the Board of Directors to amend our Amended and Restated Certificate of Incorporation (“Certificate of Incorporation”) to increase the number of authorized shares of common stock from 100,000,000 shares to 200,000,000 shares;
3.To ratify the appointment of CohnReznick LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2023;
4.To grant discretionary authority to the Board of Directors to amend our Certificate of Incorporation to effect a reverse stock split of the common stock of the Company within a range of 1-for-5 to 1-for-20, if needed to meet the minimum bid requirement under The Nasdaq Capital Market (“Nasdaq”) listing rules with the exact ratio, if any, to be determined by the Board of Directors;
5.To approve an amendment to Article XII of our Certificate of Incorporation to eliminate the 66 2/3% affirmative vote requirement for amendments to Section 1 of Article IV thereof;
6.To consider and act upon such other matters as may properly come before the meeting or any postponement or adjournment of the meeting.
|
| 2023-03-08 |
复牌提示：
2023-03-08 08:25:04 停牌，复牌日期 2023-03-08 09:00:00
|
| 2022-05-02 |
股东大会：
将于2022-06-24召开股东大会
会议内容 ▼▲
- 1.to elect two directors to the board of directors of the Company (the “Board of Directors”) to serve as Class II directors, to serve until the Company’s 2025 annual meeting of stockholders, or until in each case their respective successor is duly elected and qualified;
2.to approve an amendment to our Amended and Restated Certificate of Incorporation to increase the number of our authorized shares of common stock from 100,000,000 to 200,000,000;
3.to ratify the appointment of CohnReznick LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2022;
4.to consider and act upon such other matters as may properly come before the meeting or any postponement or adjournment of the meeting.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-04-30 |
股东大会：
将于2021-06-25召开股东大会
会议内容 ▼▲
- 1.to elect one director to the board of directors of the Company (the “Board of Directors”) to serve as the Class I director, to serve until the Company’s 2024 annual meeting of stockholders, or until his respective successor is duly elected and qualified;
2.to ratify the appointment of CohnReznick LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2021;
3.to consider and act upon such other matters as may properly come before the meeting or any postponement or adjournment of the meeting.
|